OP
Oramed Pharmaceuticals Inc
🇺🇸XNAS.ORMPUnited StatesHealthcare
$4.59USDdown -0.08 (-1.71%)OpenEnd of day5:39 PM
Price$4.59-0.08 (-1.71%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US68403P2039
- CUSIP
- 68403P104
Company
- Employees
- 0
- Headquarters
- New York, United States
- Website
- https://oramed.com
- CEO
- Mr. Nadav Kidron Esq.
Market
- Shares outstanding
- 41.6M
- Market cap
- $190.93M
Highlights
- Market cap
- $190.93M
- EPS LTM
- $4.20calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 1.09calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 10.43%
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- $174.87M+823.74%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$5.37M+66.66%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.